Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 00654F105 since 12/18/2024, largest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Orbimed Advisors LLC
13D
|
14.0% |
10/2/2026
Event 9/28/2026
|
|
| Orbimed Advisors LLC | 14.0% | ||
| Orbimed Capital GP VII LLC | 13.4% | ||
| Orbimed Advisors Israel II Ltd | 8.7% | ||
| Orbimed Israel GP II, L.P. | 8.7% | ||
| OrbiMed Genesis GP LLC | 0.6% | ||
|
LAV Biosciences Fund V, L.P.
13G
|
11.1% |
10/16/2026
Event 9/30/2026
|
|
| LAV Biosciences Fund V, L.P. | 10.5% | ||
| LAV Fund VI, L.P. | 0.3% | ||
| LAV Fund VI Opportunities, L.P. | 0.3% | ||
| Yi Shi | 11.1% | ||
|
SR One Capital Management, LLC
13D
|
9.3% |
10/5/2026
Event 9/28/2026
|
|
| SR One Capital Management, LLC | 9.3% | ||
| SR One Capital Fund I Aggregator, LP | 5.2% | ||
| SR One Capital Partners I, LP | 5.2% | ||
| SR One Capital Opportunities Fund I, LP | 1.8% | ||
| SR One Capital Opportunities Partners I, LP | 1.8% | ||
| SR One Co-Invest III, LLC | 1.7% | ||
| SR One Co-Invest III Manager, LLC | 1.7% | ||
| Amzl, LP | 0.6% | ||
| SR One Capital SMA Partners, LP | 0.6% | ||
| Simeon George | 9.3% | ||
| BCLS Fund III Investments, LP 13G | 6.3% |
10/1/2026
Event 9/24/2026
|
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 1 | 20.0 k | $399 k |